591 related articles for article (PubMed ID: 21940483)
1. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
[TBL] [Abstract][Full Text] [Related]
2. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
Edström Halling S; Söderberg MP; Berg UB
Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
[TBL] [Abstract][Full Text] [Related]
3. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy.
Kang SH; Choi SR; Park HS; Lee JY; Sun IO; Hwang HS; Chung BH; Park CW; Yang CW; Kim YS; Choi YJ; Choi BS
Nephrol Dial Transplant; 2012 Jan; 27(1):252-8. PubMed ID: 21606384
[TBL] [Abstract][Full Text] [Related]
4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
5. Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy.
Lundberg S; Gunnarsson I; Jacobson SH
Scand J Urol Nephrol; 2012 Apr; 46(2):148-55. PubMed ID: 22214235
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
7. The Oxford classification of IgA nephropathy: a retrospective analysis.
Yau T; Korbet SM; Schwartz MM; Cimbaluk DJ
Am J Nephrol; 2011; 34(5):435-44. PubMed ID: 21968096
[TBL] [Abstract][Full Text] [Related]
8. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
9. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
[TBL] [Abstract][Full Text] [Related]
10. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
12. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M
Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
[TBL] [Abstract][Full Text] [Related]
13. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis.
Piccoli A; Codognotto M; Tabbi MG; Favaro E; Rossi B
Nephrol Dial Transplant; 2010 Aug; 25(8):2583-9. PubMed ID: 20200005
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
15. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and natural history of IgA nephropathy.
Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
18. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[TBL] [Abstract][Full Text] [Related]
19. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
[TBL] [Abstract][Full Text] [Related]
20. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]